Pfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the strength of data presented on Friday showing most patients treated for a rare form of advanced lung cancer in a clinical trial were alive without the disease worsening after five years.
Tag Archive for: Data
The healthcare industry currently generates about 30 percent of the world’s data volume and that number is expanding rapidly, reaching an annual growth rate of 36 percent by next year. The life sciences are a major contributor to the expansion of the healthcare industry’s data, with a market growth rate of 11 percent up until 2032. In particular, drug development and monitoring continue to expand as the volume of information and variety of sources used in data collection increase. Organizations are now challenged with not only gathering and collecting data but also validating potential safety events.
In the sea of content today, customers – HCPs and consumers alike – are overwhelmed with information. This content might be reaching them, but not effectively resonating and activating them to change behaviors. Cutting through this noise requires creative effectiveness that can only happen by harnessing the right data, technology and AI to drive next level audience understanding and as such, next level engagement.
“Over his impressive career, John has successfully scaled technology solutions for the life sciences industry,” said Beth Beghou, CEO of Beghou Consulting. “I know he is as enthusiastic as we are about helping companies develop agile and patient-centric commercialization models.”
Med Ad News sat down with Ankit Vahia, Ph.D., who recently joined ConcentricLife as chief strategy officer, to talk about the agency’s strategy behind delivering experiences versus having a transactional relationship with clients and brands.
While it’s never actually possible to fully predict the future, we are looking ahead to how artificial intelligence and other emerging technologies – combined with the human touch of professionals – will shape the future of the business of healthcare and pharmaceuticals for generations to come. Before looking at AI’s potential impacts in the space, we must first take stock of the macro trends in healthcare.
Artificial intelligence (AI) surely stands at the forefront of one of the most transformative periods in the pharmaceutical industry. Its rapid drug discovery capabilities and potential for personalized patient care mark AI as a revolutionary influence in reshaping the pharmaceutical industry. Central to this transformation is natural language processing (NLP).
Neither UnitedHealth nor the hackers involved have commented on the alleged ransom payment, but a cryptocurrency tracing firm partially corroborated the claim on Monday.
By nearly unanimous consent artificial intelligence reached an inflection point for pharma marketers in 2023. The question of how best to take advantage of this new tool to support brands and help patients, though, remains to be seen.
MedAdNews talked to Jane Reed, director of life sciences with Linguamatics, an IQVIA company, about how pharma companies are using new AI-based technologies to advance their safety processes and other topics.